Strong Investor Demand Lifts JELI and JECX Shares on IDX Debut

RRI.CO.ID, Jakarta – Investor enthusiasm drove a strong debut for two new listings on the Indonesia Stock Exchange (IDX), with both companies’ shares immediately hitting the upper trading limit on their first day of trading on Tuesday, June 7, 2026.

PT Niramas Utama Tbk (JELI) surged 25 percent to IDR 1,125 per share from its IPO price of IDR 900, while PT Nitrasanata Dharma Tbk (JECX) climbed 24.5 percent to IDR 1,560 from IDR 1,250. The oversubscription underscored investor appetite--JELI’s pooling portion was oversubscribed 273 times, while JECX’s centralized allotment drew 62.5 times excess orders.

IDX Director of Corporate Valuation Saidu Solihin said the listings reflect how the capital market provides companies with opportunities to expand capacity, strengthen governance, and broaden access to funding. “With their listing, these companies enter a new phase that opens strategic opportunities while carrying greater responsibilities,” he said, as quoted by Antara.

Saidu reminded that an IPO is not the finish line but the beginning of a long‑term commitment. “It requires sustainable business practices, strong governance, prioritizing shareholder interests, protecting investors, and complying with all regulations,” he said, adding that IDX and stakeholders remain committed to enhancing transparency, liquidity, and investor protection.

JELI raised IDR 239.4 billion by offering 266 million shares. “We thank investors, regulators, and partners for their trust. This trust is a responsibility for us to maintain performance, strengthen governance, and deliver added value to shareholders,” Company Director Adhi S. Lukman said, expressing gratitude.

Meanwhile, JECX raised IDR 609.98 billion through nearly 488 million shares. President Director Johan A. M. M. Hutauruk said the IPO would support growth while staying true to the company’s ethos. “Through this IPO, we aim to strengthen our capital structure and support JEC’s growth, guided by our spirit of Care with Experience--patient‑oriented service backed by expertise in eye health,” he explained. ***